Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
t-cell crawled date : 2021 - 06 - 11 save search
FDA grants accelerated approval to loncastuximab tesirine-lpyl for large B-cell lymphoma
Published: 2021-06-11 (Crawled : 12:43) - fda.gov
ADCT | $4.68 7.7K
|
Health Technology
|
| O: -0.18%
H: 2.19%
C: 0.14%
fda granted approval grant t-cell
Autolus Therapeutics Presents New Data on obe-cel in r/r Indolent B Cell Lymphomas and gives an update of obe-cel in r/r Adult ALL at the European Hematology Association Virtual Congress
Published: 2021-06-11 (Crawled : 12:00) - biospace.com/
AUTL | $4.64 1.75% 96K
|
Health Technology
|
| O: 3.65%
H: 13.94%
C: 8.87%
europe cel t-cell
Mustang Bio Announces Updated Interim Phase 1/2 Data for MB-106 CD20-Targeted CAR T in Patients with Relapsed or Refractory B-cell Non-Hodgkin Lymphomas and Chronic Lymphocytic Leukemia
Published: 2021-06-11 (Crawled : 11:00) - globenewswire.com
MBIO | $0.34 3.3K
|
Health Technology
|
| O: 4.99%
H: 1.5%
C: -5.25%
FBIO | $1.8 2.86% 25K
|
Health Technology
|
| O: 3.49%
H: 0.9%
C: 0.9%
phase 1 leukemia phase 3 car-t t-cell
Gainers vs Losers
| 85% | 15% |
Top 10 Gainers
MTTR | News M | $4.625 165.81% 5.5M
|
AGBA | $2.46 96.8% 28M
|
Finance
EDBL | News | $7.37 96.01% 650K
|
CZOO | $7.74 55.11% 2.7M
|
PALI | $7.64 54.97% 14M
|
Manufacturing
OPRT | News | $3.19 41.78% 3M
|
Finance
PEGY | $0.0629 37.34% 110M
|
Manufacturing
ZAPP | $6.02 35.59% 95K
|
n/a
MLEC | $1.87 33.57% 1.6M
|
n/a
ATGL | $3.66 27.97% 150K
|
Your saved searches
Save your searches and get alerts when important news are released.